Sources were checked on 24 October 2026. The following is a preparation method, not a contract template for all Hong Kong universities or an opinion on an agreement's enforceability.
An MTA Concerns Use, Not Merely Delivery
WIPO explains material transfer agreements as arrangements governing rights and obligations involving research materials, derivatives, results and associated intellectual property. Confidentiality agreements address protected information and permitted uses; technology licences define the IP use being authorised. The actual terms require case-specific negotiation. WIPO's technology-transfer agreement guidance
HKUST's Office of Knowledge Transfer publicly lists assistance with MTAs, confidentiality agreements, technology licensing and research contracts among its functions. This identifies a university support route for HKUST teams. It does not establish that every researcher can sign on the institution's behalf or that a fixed processing time is promised. HKUST OKT major functions
Other institutions have their own processes. HKUST's page is not a Hong Kong-wide rule. A professor's willingness to provide a sample also does not establish that all relevant owners have approved commercial use.
Describe the Transfer Before Choosing the Contract Label
A coated test coupon, batch of compounds and reusable research tool should not all be described merely as “technical materials”. Prepare a non-confidential handover description before asking the authorised institutional team which agreement is appropriate.
| Handover question | Suggested record | Boundary to clarify |
|---|---|---|
| What is supplied? | Sample identifier, batch, quantity and existing instructions | Separate conditions for software, data or know-how |
| Who receives it? | Entity, laboratory and responsible person | A delivery address is not recipient authorisation |
| What is the test for? | Research question, methods and expected end date | Evaluation does not automatically include customer demonstrations or sales |
| Who else will access it? | External laboratories, engineers and onward recipients | Participation in the project does not establish onward-transfer rights |
| What will be created? | Measurements, reports, improvements and remaining material | Ownership of a sample is distinct from rights in new results |
| How does use end? | Agreed return, destruction or other permitted treatment and records | Completion does not necessarily permit indefinite retention |
These are editorial suggestions, not a university-wide checklist. Do not promise a destruction scope, delivery date or results use that the team cannot actually perform merely to complete a form.
External Testing and New Uses Need Early Attention
Consider an analytical example. A Hong Kong research team supplies a surface-treatment sample, and a startup plans durability testing at a Shenzhen laboratory. Initially, only the university contact and the company's engineer discuss the work. Later, a customer asks for the sample to be installed in demonstration equipment. The change affects the people handling it, its purpose and its presentation, not just the testing address.
A better preparation method is to identify the external laboratory and task in the original plan, then refer additional uses to the agreement owner before proceeding. Asking after a sample has been passed on, dismantled or demonstrated may leave the project outside its agreed scope. Physical proximity between Hong Kong and Shenzhen does not remove institutional or contractual boundaries.
This does not mean every cross-border sample requires an identical agreement. Nor does signing an MTA authorise shipment of every substance or item. Where relevant, transport, export controls, biosafety, personal data and research ethics require their own professional review. This article provides no workaround for those requirements.
Separate Results, Improvements and Publication Questions
A test report may combine the company's process information, university background technology and newly generated data. Saying “the results are jointly owned” may not tell an engineer whether the report can be sent to a customer. It may also leave future invention protection unresolved.
Break the discussion into usable questions. Who receives the full report? Who can use measurements for internal decisions? What may be published, included in fundraising or used in marketing? How will potentially new inventions be referred to the relevant institutional teams? These are negotiation questions, not an assumption that ownership must belong to the university, company or both.
Academic publication, an exhibition and a commercial launch can also run on different calendars. Teams can agree who reviews proposed disclosure, who follows up and how unresolved questions affect scheduling. Silence should not be treated as automatic permission unless the actual agreement, professionally reviewed, provides for that outcome.
Moving Towards a Product Requires Another Rights Review
A successful test may justify further research. It does not independently establish exclusivity, manufacturing rights, sublicensing rights or sales rights in a particular market. Testing fees, material costs and licence consideration should be understood separately. Paying for a test is not a basis for describing the company as having “acquired university technology”.
For the next university discussion, bring completed test records, the proposed next use, any continuing need for materials and the commercial scope to be discussed. That is more specific than requesting “full authorisation”. A related distinction appears in our guide to technology options, licences and university startup support.
When speaking to investors or buyers, explain the work currently permitted and its limits rather than relying on the phrase “university partnership”. Do not disclose protected reports, use university branding as endorsement, or present a proposed product route as institutionally approved without permission.
A Jimhang Discussion Can Start With a Shared Work Description
University teams and industry partners approaching Jimhang Capital can begin with a non-confidential outline: what needs validation, why an external engineering partner is needed, which uses are confirmed and which still require institutional action. Restricted materials, unpublished technical detail and confidential data are unnecessary for that first discussion. Do not send samples, original contracts or private project files to a general enquiry mailbox.
The useful discussion is the connection between test objectives, scheduling and commercial questions. It does not replace university authority, contract review, transport permission or product-performance assessment. Contact justin@jimscapital.cn or explore related questions in the research library. This is editorial analysis, not Justin Zhan's personal account or an interview, and it does not imply an unverified relationship between Jimhang Capital and the university cited.